Search results
Recursion Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Recursion Pharmaceuticals, Inc.? Here are five stocks we like better.
- Recursion advanced its pipeline, moving its first neuroscience target from the Roche/Genentech
The Hanover Insurance Group Q2 Earnings Call Highlights
The Hanover Insurance Group (NYSE:THG) reported record second-quarter operating performance, citing improved underwriting margins, accelerating premium growth and higher investment income across
Alnylam Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Alnylam Pharmaceuticals, Inc.? Here are five stocks we like better.
- Second-quarter revenue surged 74% to approximately $1.2 billion, driven by AMVUTTRA, which
Madrigal Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Madrigal Pharmaceuticals, Inc.? Here are five stocks we like better.
- Rezdiffra sales rose 71% year over year to $364.3 million in Q2 2026, with nearly $1.3 billion in
OraSure Technologies Q2 Earnings Call Highlights
Key Points
- Interested in OraSure Technologies, Inc.? Here are five stocks we like better.
- Q2 revenue rose 9.7% sequentially to $30.6 million, exceeding guidance, as diagnostic-products revenue
Information Services Group Q2 Earnings Call Highlights
Key Points
- Interested in Information Services Group, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue rose 6.4% to $65.5 million and adjusted EBITDA
Tandem Diabetes Care Q2 Earnings Call Highlights
Key Points
- Interested in Tandem Diabetes Care, Inc.? Here are five stocks we like better.
- Record second-quarter performance: Worldwide sales rose 6% year over year to $255 million, while pump